Blog

Jared Simmons shares an episode from his podcast, What is Innovation. In this episode, he interviews William A. Lumpkin, Head of New Products Strategy & Business Development for Alexion, Astra Zeneca Rare Disease Business Unit. Will shares how innovation works within the pharmaceutical industry and how marketing and science differs especially in commercialization.

EPISODE SUMMARY

William A. Lumpkin is Head of New Products Strategy & Business Development for Alexion, Astra Zeneca Rare Disease Business Unit. Will shares how innovation works within the pharmaceutical industry and how marketing and science differs especially in commercialization.

William A. Lumpkin is Head of New Products Strategy & Business Development for Alexion, Astra Zeneca Rare Disease Business Unit. His business acumen, enterprise leadership, and passion for cross-functional collaboration helps bring new medicines to people living with rare diseases across the world. Prior to Alexion, he held a diverse set of U.S. and global commercial leadership roles at Takeda, Baxter, Baxalta, Shire, and Procter & Gamble spanning functional disciplines, product lifecycles and therapeutic areas. William is a proud father of three (Ailey, Sage, and Liam), loving husband (Layla), and resilient Indiana University sports fan. He also maintains interests in urban community development initiatives and was on faculty at the University of North Carolina Kenan Flagler School of Business online MBA program. He earned his MBA from the University of Chicago Booth School of Business and B.S. Finance from Indiana University.

Key Points include:

• Stereotyped view of Pharmaceuticals
• Large companies vs smaller companies: Providing real value to people
• Intersection and divergence of Marketing and Scientists

Access the podcast, Innovation is finding a way, on Outlastllc.com.